Theravance Biopharma (TBPH) Tops Q2 EPS by 21c
Get Alerts TBPH Hot Sheet
Join SI Premium – FREE
Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($0.80), $0.21 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $15.41 million.
For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Universal Health Realty (UHT) Reports Q1 EPS of $0.38
- ESSA Bancorp (ESSA) Tops Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!